| Product Code: ETC6740154 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Companion Diagnostics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 China Companion Diagnostics Market - Industry Life Cycle |
3.4 China Companion Diagnostics Market - Porter's Five Forces |
3.5 China Companion Diagnostics Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 China Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 China Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in China leading to the demand for personalized medicine and companion diagnostics |
4.2.2 Growing awareness and adoption of precision medicine in healthcare practices |
4.2.3 Government initiatives and investments to promote precision medicine and companion diagnostics in China |
4.3 Market Restraints |
4.3.1 Regulatory challenges and complexities in obtaining approvals for companion diagnostics in China |
4.3.2 Limited reimbursement policies for companion diagnostics leading to affordability issues for patients |
4.3.3 Lack of skilled professionals in the field of genomics and molecular diagnostics in China |
5 China Companion Diagnostics Market Trends |
6 China Companion Diagnostics Market, By Types |
6.1 China Companion Diagnostics Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 China Companion Diagnostics Market Revenues & Volume, By Technology Type, 2021- 2031F |
6.1.3 China Companion Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.4 China Companion Diagnostics Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.1.5 China Companion Diagnostics Market Revenues & Volume, By Next Generation Sequencing (NGS), 2021- 2031F |
6.1.6 China Companion Diagnostics Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.1.7 China Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 China Companion Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 China Companion Diagnostics Market Revenues & Volume, By Neurology, 2021- 2031F |
6.2.4 China Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 China Companion Diagnostics Market Import-Export Trade Statistics |
7.1 China Companion Diagnostics Market Export to Major Countries |
7.2 China Companion Diagnostics Market Imports from Major Countries |
8 China Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics in clinical practice |
8.2 Number of partnerships and collaborations between diagnostic companies and healthcare providers for companion diagnostics |
8.3 Investment in research and development of new companion diagnostic tests |
8.4 Number of publications and clinical trials related to companion diagnostics in China |
8.5 Patient outcomes and treatment efficacy improvement with the use of companion diagnostics. |
9 China Companion Diagnostics Market - Opportunity Assessment |
9.1 China Companion Diagnostics Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 China Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 China Companion Diagnostics Market - Competitive Landscape |
10.1 China Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 China Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here